Search results
Roche's (RHHBY) Tecentriq Subcutaneous Gets Approval in the EU
Zacks via Yahoo Finance· 4 months agoRoche RHHBY announced that the European Commission has granted marketing authorization to...
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
Benzinga via Yahoo Finance· 1 year agoExelixis Inc (NASDAQ: EXEL) announced that the CONTACT-01 study did not meet its primary endpoint of...
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
Benzinga via Yahoo Finance· 2 years agoAmgen Inc (NASDAQ: AMGN) announced new data sets from its thoracic oncology portfolio, including new...
Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, BMRN was down...
Exelixis' (EXEL) Cabozantinib Combo Study Fails to Meet Goal
Zacks via Yahoo Finance· 1 year agoShares of Exelixis, Inc. EXEL were down 0.17% on Mar 3 after the company announced the failure of...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 9 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Exelixis' (EXEL) Prostate Cancer Study Meets Primary Endpoint
Zacks via Yahoo Finance· 9 months agoExelixis, Inc. EXEL and partner Ipsen announced that the late-stage CONTACT-02 study achieved one of...
Biotech Stocks Rally After Roche's (RHHBY) Accidental Data Leak
Zacks via Yahoo Finance· 9 months agoOn Aug 23, shares of several biotech companies rose after pharma-giant Rocheās RHHBY stated that it...